Methylcobalamin is the active, coenzyme form of vitamin B12. Cyanocobalamin, the most common form of supplemental B12, must be converted first into hydroxocobalamin, and then into adenosylcobalamin, which is finally converted into methylcobalamin. Since cyanocobalamin has to undergo this extensive conversion process, supplementation with methylcobalamin is preferable, and it is also the specific form of B12 shown to support the brain and nervous system. In humans, supplementation with high doses of methylcobalamin has been shown to provide neurological support in people with degenerative nerve conditions such as Bell’s palsy, multiple sclerosis, Lou Gehrig’s disease and degenerative spinal conditions. Methylcobalamin may also help normalize sleep-wake cycles, providing a better quality sleep for some.
AOR’s Methyl B12 – 5 mg provides 5mg in an easy to take lozenge making it ideal for those who have neurological conditions or nerve problems. Vegetarians, elderly people, those suffering from pernicious or megaloblastic anemia, atrophic gastritis, Celiac disease, Crohn’s disease or other types of inflammatory gastrointestinal disorders are at greater risk for B12 deficiency and may benefit from high doses of methylcobalamin.
While the RDA (Recommended Dietary Allowance) for vitamin B12 in Canada is just 2.4 micrograms and the upper limit is just 1 milligram, AOR’s Methyl B12 – 5 mg provides a high, clinically effective dosage of the most bioavailable form of vitamin B12 in a convenient and pleasant-tasting lozenge form.